ArticleGut2018
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8
Article in Gut, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Article
- BAG3 in human tumors.Frontiers in oncology · 2025Article
- Mitochondria-Associated Membranes in Aging and Senescence.Aging and disease · 2024Review
- Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer.Biology of sex differences · 2024Article
- Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment.Cancers · 2023Review
- Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma.Cancer biology & medicine · 2023Article
- Toxicity in combined therapies for tumours treatments: a lesson from BAG3 in the TME?Frontiers in immunology · 2023Article
- Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model.Journal of cancer research and clinical oncology · 2022Article
- Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth.Cell death discovery · 2022Article
- The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies.Frontiers in immunology · 2022Review
- BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration.Journal of cellular biochemistry · 2022Article
- Review
- An emerging role for BAG3 in gynaecological malignancies.British journal of cancer · 2021Review
- TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer.Frontiers in cell and developmental biology · 2021Article
- Article
- BAG3 interacts with p53 in endometrial carcinoma.Cellular oncology (Dordrecht, Netherlands) · 2020Article
- Comment on: 'Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients'.British journal of cancer · 2020Article
- Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer.Frontiers in cell and developmental biology · 2020Review
- Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer.Molecular oncology · 2019Article
- Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma.The Journal of experimental medicine · 2019Article
Corrections and comments
- Comment on
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.